+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease



Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease



Acta Diabetologica 50(3): 443-449



The prevalence of very severe obesity has increased progressively and faster than other classes of obesity over the last years. It is unclear whether the prevalence of obesity-related complications and health risks increases progressively or reaches a plateau above a certain degree of obesity. The aim of our study was to investigate whether the severity of obesity was correlated with the prevalence of type 2 diabetes mellitus (T2DM), impaired fasting glucose, impaired glucose tolerance (IGT), metabolic syndrome (MS), and cardiovascular diseases (CVDs) in a large cohort of patients with different degrees of obesity. A cross-sectional study was conducted in 938 obese patients without a previous diagnosis of diabetes. Patients were assigned to different categories of obesity: mild-moderate obesity (BMI 30-39.9 kg/m(2)), morbid obesity (BMI 40-49.9 kg/m(2)), and super-obesity (SO, BMI ≥50 kg/m(2)). The prevalence of IGF, IGT, screen-detected T2DM, MS, and CVD was higher in SO patients than in the other groups. Interestingly, the association between SO and either MS or CVD was independent of glucose tolerance status, indicating that factors other than glucose metabolism also favor cardio-metabolic complications in obese patients. In patients without screen-detected T2DM (n = 807), insulin sensitivity and secretion OGTT-derived indexes indicated that SO patients had the worst glucose homeostasis relative to the other categories of obesity, which was indicated by the most reduced disposition index in these patients, a predictor of future T2DM. In conclusion, SO patients have an extremely high prevalence of glucose metabolism deterioration, and cardio-metabolic complications are more prevalent in these patients compared to less obese patients.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036785663

Download citation: RISBibTeXText

PMID: 23447004

DOI: 10.1007/s00592-013-0460-3


Related references

Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity. Archives of Internal Medicine 167(7): 642-648, 2007

Fibrinogen, other cardiovascular risk factors and diabetes mellitus in Hong Kong: a community with high prevalence of Type 2 diabetes mellitus and impaired glucose tolerance. Diabetic Medicine 17(11): 798-806, 2000

The prevalence of metabolic syndrome in obese and non-obese patients with newly-diagnosed type 2 diabetes mellitus. International Journal of Obesity 24(Suppl. 1): S80, 2000

Prevalence of diabetes mellitus among obese and non-obese patients with coronary artery disease. Journal of Ayub Medical College Abbottabad 22(3): 64-67, 2012

Safety and efficacy of Roux-en-Y gastric bypass to treat type 2 diabetes mellitus in non-severely obese patients. Obesity Surgery 21(9): 1330-1336, 2011

Predictors of Long-Term Remission and Relapse of Type 2 Diabetes Mellitus Following Gastric Bypass in Severely Obese Patients. Obesity Surgery 28(1): 195-203, 2018

Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. Journal of the American College of Surgeons 216(4): 545-56; Discussion 556-8, 2013

High prevalence of celiac disease among patients with insulin-dependent (type I) diabetes mellitus. American Journal of Gastroenterology 92(12): 2210-2212, 1997

Lipid-lowering treatment patterns among patients with type 2 diabetes mellitus with high cardiovascular disease risk. Bmj Open Diabetes Research and Care 3(1): E000132, 2015

Prevalence and severity of periodontal disease in type 2 diabetes mellitus (non-insulin-dependent diabetes mellitus) patients in Bangalore city: An epidemiological study. Journal of Indian Society of Periodontology 17(1): 25-29, 2013

Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk. Diabetes Obesity and Metabolism 14(1): 30-39, 2012

Prevalence of type 2 diabetes mellitus, other cardiovascular risk factors, and cardiovascular disease in Turkish and Moroccan immigrants in North West Europe: a systematic review. Preventive Medicine 39(6): 1068-1076, 2004

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study. American Journal of Nephrology 45(2): 136-145, 2017

High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels. Journal of Clinical Endocrinology and Metabolism 100(6): 2231-2238, 2015

High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels. Journal of Clinical Endocrinology and Metabolism 100(5):, 2014